HB-PTSD-001: Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

CONDITION

Mental Health

GENDER

AGE GROUP

From 18

to 65 years

STATUS

Not yet recruiting

Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

Studies Contact Form

Approved By: Bellberry              

Clinical Trial Registry Link:


Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260